Alfresa (OTC:ARHCF) Rating Increased to Neutral at Nomura

Nomura upgraded shares of Alfresa (OTC:ARHCFGet Rating) from a reduce rating to a neutral rating in a report released on Wednesday morning, The Fly reports.

Shares of ARHCF opened at $18.70 on Wednesday. Alfresa has a one year low of $18.60 and a one year high of $19.40.

About Alfresa (Get Rating)

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies.

Read More

The Fly logo

Receive News & Ratings for Alfresa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alfresa and related companies with MarketBeat.com's FREE daily email newsletter.